The regulation of muscle mass by endogenous glucocorticoids

Frontiers in Physiology

Volumn 6, Issue FEB, 2015, Pages

  Braun, Theodore P ^a,b   Marks, Daniel L ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cachexia; Catabolism; Glucococorticoids; HPA axis; Muscle; Protein synthesis; Skeletal; Wasting

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROXYSTEROID DEHYDROGENASE; INSULIN; MICRORNA; MYOSTATIN; REACTIVE OXYGEN METABOLITE; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3;

AUTOPHAGY; CACHEXIA; CATABOLISM; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE FUNCTION; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KIDNEY FAILURE; METABOLIC ACIDOSIS; MUSCLE ATROPHY; MUSCLE MASS; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 84926480754     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00012     Document Type: Review

References (101)

1. Akita, S., Webster, J., Ren, S. G., Takino, H., Said, J., Zand, O., et al. (1995). Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin. Invest . 95, 1288-1298. doi: 10.1172/JCI117779
2. Allen, D. L., and Loh, A. S. (2011). Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am. J. Physiol. Cell Physiol . 300, C124-C137. doi: 10.1152/ajpcell.00142.2010
3. Almeida, M., Han, L., Ambrogini, E., Weinstein, R. S., and Manolagas, S. C. (2011). Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J. Biol. Chem . 286, 44326-44335. doi: 10.1074/jbc.M111.283481
4. Baehr, L. M., Furlow, J. D., and Bodine, S. C. (2011). Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J. Physiol. (Lond) . 589, 4759-4776. doi: 10.1113/jphysiol.2011.212845
5. Baracos, V., Rodemann, H. P., Dinarello, C. A., and Goldberg, A. L. (1983). Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N. Engl. J. Med . 308, 553-558. doi: 10.1056/NEJM198303103081002
6. Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., and Besedovsky, H. (1987). Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238, 524-526.
7. Besedovsky, H., del Rey, A., Sorkin, E., and Dinarello, C. A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654.
8. Bethin, K. E., Vogt, S. K., and Muglia, L. J. (2000). Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. U.S.A . 97, 9317-9322. doi: 10.1073/pnas.97.16.9317
9. Biedasek, K., Andres, J., Mai, K., Adams, S., Spuler, S., Fielitz, J., et al. (2011). Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. PLoS ONE 6:e16674. doi: 10.1371/journal.pone.0016674
10. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., et al. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708. doi: 10.1126/science.1065874
11. Braun, T. P., Grossberg, A. J., Krasnow, S. M., Levasseur, P. R., Szumowski, M., Zhu, X. X., et al. (2013). Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle. FASEB J . 27, 3572-3582. doi: 10.1096/fj.13-230375
12. Braun, T. P., and Marks, D. L. (2010). Pathophysiology and treatment of inflammatory anorexia in chronic disease. J. Cachexia Sarcopenia Muscle 1, 135-145. doi: 10.1007/s13539-010-0015-1
13. Braun, T. P., Zhu, X., Szumowski, M., Scott, G. D., Grossberg, A. J., Levasseur, P. R., et al. (2011). Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J. Exp. Med . 208, 2449-2463. doi: 10.1084/jem.20111020
14. Budanov, A. V., and Karin, M. (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460. doi: 10.1016/j.cell.2008.06.028
15. Buller, K. M. (2001). Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis. Clin. Exp. Pharmacol. Physiol . 28, 581-589. doi: 10.1046/j.1440-1681.2001.03490.x
16. Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., et al. (2004). IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285-298. doi: 10.1016/j.cell.2004.09.027
17. Castillero, E., Alamdari, N., Aversa, Z., Gurav, A., and Hasselgren, P.-O. (2013). PPARΒ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting. PLoS ONE 8:e59726. doi: 10.1371/journal.pone.0059726
18. Chapman, K., Holmes, M., and Seckl, J. (2013). 11Β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol. Rev . 93, 1139-1206. doi: 10.1152/physrev.00020.2012
19. Ching, S., Zhang, H., Belevych, N., He, L., Lai, W., Pu, X.-A., et al. (2007). Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J. Neurosci . 27, 10476-10486. doi: 10.1523/JNEUROSCI.3357-07.2007
20. Clarke, B. A., Drujan, D., Willis, M. S., Murphy, L. O., Corpina, R. A., Burova, E., et al. (2007). The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab . 6, 376-385. doi: 10.1016/j.cmet.2007.09.009
21. Cohen, S., Brault, J. J., Gygi, S. P., Glass, D. J., Valenzuela, D. M., Gartner, C., et al. (2009). During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J. Cell Biol . 185, 1083-1095. doi: 10.1083/jcb.200901052
22. Csibi, A., Leibovitch, M. P., Cornille, K., Tintignac, L. A., and Leibovitch, S. A. (2009). MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines. J. Biol. Chem . 284, 4413-4421. doi: 10.1074/jbc.M807641200
23. Cushing, H. (1994). The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. Obes. Res . 2, 486-508.
24. De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E., and Haegeman, G. (2000). Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. U.S.A . 97, 3919-3924. doi: 10.1073/pnas.97.8.3919
25. Dong, Y., Pan, J. S., and Zhang, L. (2013). Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction. PLoS ONE 8:e58554. doi: 10.1371/journal.pone.0058554
26. Doyle, A., Zhang, G., Abdel Fattah, E. A., Eissa, N. T., and Li, Y.-P. (2011). Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J . 25, 99-110. doi: 10.1096/fj.10-164152
27. Ericsson, A., Arias, C., and Sawchenko, P. E. (1997). Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci . 17, 7166-7179.
28. Ericsson, A., Liu, C., Hart, R. P., and Sawchenko, P. E. (1995). Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol . 361, 681-698. doi: 10.1002/cne.903610410
29. Exton, M. S. (1997). Infection-induced anorexia: active host defence strategy. Appetite 29, 369-383. doi: 10.1006/appe.1997.0116
30. Frijters, R., Fleuren, W., Toonen, E. J. M., Tuckermann, J. P., Reichardt, H. M., van der Maaden, H., et al. (2010). Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics 11:359. doi: 10.1186/1471-2164-11-359
31. Frost, R. A., Nystrom, G. J., Jefferson, L. S., and Lang, C. H. (2007). Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am. J. Physiol. Endocrinol. Metab . 292, E501-E512. doi: 10.1152/ajpendo.00359.2006
32. Fülster, S., Tacke, M., Sandek, A., Ebner, N., Tschöpe, C., Doehner, W., et al. (2013). Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur. Heart J . 34, 512-519. doi: 10.1093/eurheartj/ehs381
33. Furlow, J. D., Watson, M. L., Waddell, D. S., Neff, E. S., Baehr, L. M., Ross, A. P., et al. (2013). Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy. Physiol. Genomics 45, 1168-1185. doi: 10.1152/physiolgenomics.00022.2013
34. García-Bueno, B., Serrats, J., and Sawchenko, P. E. (2009). Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary-adrenal axis activation by inflammatory stimuli. J. Neurosci . 29, 12970-12981. doi: 10.1523/JNEUROSCI.2373-09.2009
35. Gilson, H., Schakman, O., Combaret, L., Lause, P., Grobet, L., Attaix, D., et al. (2007). Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148, 452-460. doi: 10.1210/en.2006-0539
36. Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., and Goldberg, A. L. (2001). Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. U.S.A . 98, 14440-14445. doi: 10.1073/pnas.251541198
37. Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C. Y., and Baldwin, A. S. (2000). NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363-2366. doi: 10.1126/science.289.5488.2363
38. Hammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C. B., et al. (2006). Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med . 203, 15-20. doi: 10.1084/jem.20051753
39. Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev . 12, 123-137. doi: 10.1016/S0149-7634(88)80004-6
40. He, W. A., Berardi, E., Cardillo, V. M., Acharyya, S., Aulino, P., Thomas-Ahner, J., et al. (2013). NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J. Clin. Invest . 123, 4821-4835. doi: 10.1172/JCI68523
41. Heikinheimo, O., Pesonen, U., Huupponen, R., Koulu, M., and Lähteenmäki, P. (1994). Hepatic metabolism and distribution of mifepristone and its metabolites in rats. Hum. Reprod . 9(Suppl. 1), 40-46.
42. Hoberman, H. D. (1950). Endocrine regulation of amino acid protein metabolism during fasting. Yale J. Biol. Med . 22, 341-367.
43. Hu, Z., Wang, H., Lee, I. H., Du, J., and Mitch, W. E. (2009). Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J. Clin. Invest . 119, 3059-3069. doi: 10.1172/JCI38770
44. Jagoe, R. T., Lecker, S. H., Gomes, M., and Goldberg, A. L. (2002). Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J . 16, 1697-1712. doi: 10.1096/fj.02-0312com
45. Jin, B., and Li, Y.-P. (2007). Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J. Cell. Biochem . 100, 960-969. doi: 10.1002/jcb.21060
46. Kadmiel, M., and Cidlowski, J. A. (2013). Glucocorticoid receptor signaling in health and disease. Trends Pharmacol. Sci . 34, 518-530. doi: 10.1016/j.tips.2013.07.003
47. Kluger, M. J. (1978). The evolution and adaptive value of fever. Am. Sci . 66, 38-43.
48. Kukreti, H., Amuthavalli, K., Harikumar, A., Sathiyamoorthy, S., Feng, P. Z., Anantharaj, R., et al. (2013). Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy. J. Biol. Chem . 288, 6663-6678. doi: 10.1074/jbc.M112.390369
49. Kuo, T., Lew, M. J., Mayba, O., Harris, C. A., Speed, T. P., and Wang, J.-C. (2012). Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc. Natl. Acad. Sci. U.S.A . 109, 11160-11165. doi: 10.1073/pnas.1111334109
50. Lagirand-Cantaloube, J., Offner, N., Csibi, A., Leibovitch, M. P., Batonnet-Pichon, S., Tintignac, L. A., et al. (2008). The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J . 27, 1266-1276. doi: 10.1038/emboj.2008.52
51. Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., and Kambadur, R. (2002). Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem . 277, 49831-49840. doi: 10.1074/jbc.M204291200
52. Laplante, M., and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293. doi: 10.1016/j.cell.2012.03.017
53. Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., et al. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J . 18, 39-51. doi: 10.1096/fj.03-0610com
54. Lee, S. J., and McPherron, A. C. (2001). Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U.S.A . 98, 9306-9311. doi: 10.1073/pnas.151270098
55. Li, Y.-P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D. L., et al. (2005). TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J . 19, 362-370. doi: 10.1096/fj.04-2364com
56. Llovera, M., García-Martínez, C., Costelli, P., Agell, N., Carbó, N., López-Soriano, F. J., et al. (1996). Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486. Cancer Lett . 99, 7-14.
57. Lokireddy, S., Wijesoma, I. W., Teng, S., Bonala, S., Gluckman, P. D., McFarlane, C., et al. (2012). The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab . 16, 613-624. doi: 10.1016/j.cmet.2012.10.005
58. Lützner, N., Kalbacher, H., Krones-Herzig, A., and Rösl, F. (2012). FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLoS ONE 7:e42166. doi: 10.1371/journal.pone.0042166
59. Ma, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N., and Bhasin, S. (2001). Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro . Am. J. Physiol. Endocrinol. Metab . 281, E1128-E1136.
60. Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., et al. (2007). FoxO3 controls autophagy in skeletal muscle in vivo . Cell Metab . 6, 458-471. doi: 10.1016/j.cmet.2007.11.001
61. Masferrer, J. L., Seibert, K., Zweifel, B., and Needleman, P. (1992). Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A . 89, 3917-3921. doi: 10.1073/pnas.89.9.3917
62. May, R. C., Kelly, R. A., and Mitch, W. E. (1986). Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J. Clin. Invest . 77, 614-621. doi: 10.1172/JCI112344
63. May, R. C., Kelly, R. A., and Mitch, W. E. (1987). Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. J. Clin. Invest . 79, 1099-1103. doi: 10.1172/JCI112924
64. McClung, J. M., Judge, A. R., Powers, S. K., and Yan, Z. (2010). p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am. J. Physiol. Cell Physiol . 298, C542-C549. doi: 10.1152/ajpcell.00192.2009
65. McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., et al. (2006). Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J. Cell. Physiol . 209, 501-514. doi: 10.1002/jcp.20757
66. McPherron, A. C., Lawler, A. M., and Lee, S. J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90. doi: 10.1038/387083a0
67. Mittal, A., Bhatnagar, S., Kumar, A., Lach-Trifilieff, E., Wauters, S., Li, H., et al. (2010). The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J. Cell Biol . 188, 833-849. doi: 10.1083/jcb.200909117
68. Morgan, S. A., Sherlock, M., Gathercole, L. L., Lavery, G. G., Lenaghan, C., Bujalska, I. J., et al. (2009). 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes 58, 2506-2515. doi: 10.2337/db09-0525
69. Noori, N., Kopple, J. D., Kovesdy, C. P., Feroze, U., Sim, J. J., Murali, S. B., et al. (2010). Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin. J. Am. Soc. Nephrol . 5, 2258-2268. doi: 10.2215/CJN.02080310
70. Pilkis, S. J., el-Maghrabi, M. R., and Claus, T. H. (1988). Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Biochem . 57, 755-783. doi: 10.1146/annurev.bi.57.070188.003543
71. Rebbapragada, A., Benchabane, H., Wrana, J. L., Celeste, A. J., and Attisano, L. (2003). Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol. Cell. Biol . 23, 7230-7242. doi: 10.1128/MCB.23.20.7230-7242.2003
72. Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., et al. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.
73. Reichardt, H. M., Tuckermann, J. P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., et al. (2001). Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J . 20, 7168-7173. doi: 10.1093/emboj/20.24.7168
74. Rivadeneira, D. E., Naama, H. A., McCarter, M. D., Fujita, J., Evoy, D., Mackrell, P., et al. (1999). Glucocorticoid blockade does not abrogate tumor-induced cachexia. Nutr. Cancer 35, 202-206. doi: 10.1207/S15327914NC352_16
75. Sacheck, J. M., Hyatt, J.-P. K., Raffaello, A., Jagoe, R. T., Roy, R. R., Edgerton, V. R., et al. (2007). Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J . 21, 140-155. doi: 10.1096/fj.06-6604com
76. Sandri, M. (2010). Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am. J. Physiol. Cell Physiol . 298, C1291-C1297. doi: 10.1152/ajpcell.00531.2009
77. Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., et al. (2006). PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. U.S.A . 103, 16260-16265. doi: 10.1073/pnas.0607795103
78. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., et al. (2004). Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412. doi: 10.1016/S0092-8674(04)00400-3
79. Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., and Vale, W. (1987). Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238, 522-524.
80. Shen, H., Liu, T., Fu, L., Zhao, S., Fan, B., Cao, J., et al. (2013). Identification of microRNAs involved in dexamethasone-induced muscle atrophy. Mol. Cell. Biochem . 381, 105-113. doi: 10.1007/s11010-013-1692-9
81. Shimizu, N., Yoshikawa, N., Ito, N., Maruyama, T., Suzuki, Y., Takeda, S.-I., et al. (2011). Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab . 13, 170-182. doi: 10.1016/j.cmet.2011.01.001
82. Song, Y.-H., Li, Y., Du, J., Mitch, W. E., Rosenthal, N., and Delafontaine, P. (2005). Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest . 115, 451-458. doi: 10.1172/JCI22324
83. Sun, H., Gong, Y., Qiu, J., Chen, Y., Ding, F., and Zhao, Q. (2014). TRAF6 inhibition rescues dexamethasone-induced muscle atrophy. Int. J. Mol. Sci . 15, 11126-11141. doi: 10.3390/ijms150611126
84. Suzuki, N., Motohashi, N., Uezumi, A., Fukada, S.-I., Yoshimura, T., Itoyama, Y., et al. (2007). NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J. Clin. Invest . 117, 2468-2476. doi: 10.1172/JCI30654
85. Tan, B. H. L., Birdsell, L. A., Martin, L., Baracos, V. E., and Fearon, K. C. H. (2009). Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin. Cancer Res . 15, 6973-6979. doi: 10.1158/1078-0432.CCR-09-1525
86. Tessitore, L., Costelli, P., and Baccino, F. M. (1994). Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem. J . 299(Pt 1), 71-78.
87. Tiao, G., Fagan, J., Roegner, V., Lieberman, M., Wang, J. J., Fischer, J. E., et al. (1996). Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest . 97, 339-348. doi: 10.1172/JCI118421
88. Tuckermann, J. P., Reichardt, H. M., Arribas, R., Richter, K. H., Schütz, G., and Angel, P. (1999). The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell Biol . 147, 1365-1370. doi: 10.1083/jcb.147.7.1365
89. Vandevyver, S., Dejager, L., Van Bogaert, T., Kleyman, A., Liu, Y., Tuckermann, J., et al. (2012). Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J. Clin. Invest . 122, 2130-2140. doi: 10.1172/JCI60006
90. Wada, S., Kato, Y., Okutsu, M., Miyaki, S., Suzuki, K., Yan, Z., et al. (2011). Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J. Biol. Chem . 286, 38456-38465. doi: 10.1074/jbc.M111.271270
91. Waddell, D. S., Baehr, L. M., van den Brandt, J., Johnsen, S. A., Reichardt, H. M., Furlow, J. D., et al. (2008). The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am. J. Physiol. Endocrinol. Metab . 295, E785-E797. doi: 10.1152/ajpendo.00646.2007
92. Wang, H., Kubica, N., Ellisen, L. W., Jefferson, L. S., and Kimball, S. R. (2006). Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J. Biol. Chem . 281, 39128-39134. doi: 10.1074/jbc.M610023200
93. Watkins, L. R., Goehler, L. E., Relton, J. K., Tartaglia, N., Silbert, L., Martin, D., et al. (1995). Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci. Lett . 183, 27-31. doi: 10.1016/0304-3940(94)11105-R
94. Wei, P., Inamdar, N., and Vedeckis, W. V. (1998). Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol. Endocrinol . 12, 1322-1333. doi: 10.1210/mend.12.9.0158
95. Wendelaar Bonga, S. E. (1997). The stress response in fish. Physiol. Rev . 77, 591-625.
96. Wing, S. S., and Goldberg, A. L. (1993). Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol . 264, E668-E676.
97. Wise, J. K., Hendler, R., and Felig, P. (1973). Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J. Clin. Invest . 52, 2774-2782. doi: 10.1172/JCI107473
98. Wray, C. J., Mammen, J. M. V., Hershko, D. D., and Hasselgren, P.-O. (2003). Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int. J. Biochem. Cell Biol . 35, 698-705. doi: 10.1016/S1357-2725(02)00341-2
99. You, J.-M., Yun, S.-J., Nam, K. N., Kang, C., Won, R., and Lee, E. H. (2009). Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can. J. Physiol. Pharmacol . 87, 440-447. doi: 10.1139/y09-027
100. Zamir, O., Hasselgren, P. O., Higashiguchi, T., Frederick, J. A., and Fischer, J. E. (1992). Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm . 1, 247-250. doi: 10.1155/S0962935192000371
101. Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., et al. (2010). Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531-543. doi: 10.1016/j.cell.2010.07.011